FDA Adverse Event Injury Summary report: N

WATCHMAN LAA FLX CLOSURE DEVICE & DELIVERY SYSTEM

MDR report key: 15882606 · Received November 29, 2022

Report

Report Number
2124215-2022-49471
Event Type
Injury
Date Received
November 29, 2022
Date of Event
November 2, 2022
Report Date
November 29, 2022
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NGV
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DATE OF EVENT: PUBLICATION DATE OF 02NOV2022 USED AS EVENT DATE IS UNKNOWN. VUKOMANOVIC, D. ET AL. (2022). MASSIVE DEVICE-RELATED THROMBUS AFTER LAA OCCLUSION INTRAOPERATIVE INSIGHTS INTO MECHANISM. JOURNALS OF THE AMERICAN COLLEGE OF CARDIOLOGY, VOLUME 4 (ISSUE 21), 1409-1413.

Description of Event or Problem · 0

REPORTED VIA JOURNAL ARTICLE. IT WAS REPORTED THAT THROMBOSIS OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS SUCCESSFULLY PERFORMED USING A 31MM WATCHMAN FLX LAA CLOSURE DEVICE WITH DELIVERY SYSTEM (WDS). SIX (6) MONTHS POST INDEX PROCEDURE, ANTI-COAGULATION AND DUAL ANTIPLATELET THERAPIES WERE DISCONTINUED, AND ASPIRIN WAS INITIATED. AT AN UNSPECIFIED TIME POST INDEX PROCEDURE, THE PATIENT REPORTED PROGRESSIVE DYSPNEA ON EXERTION. DURING AN ECHOCARDIOGRAPHIC EVALUATION, PROGRESSION OF CARDIAC VALVULAR DISEASE WAS DISCOVERED. TWENTY-SIX (26) MONTHS POST INDEX PROCEDURE, THE PATIENT UNDERWENT AN AORTIC VALVE REPLACEMENT, MITRAL VALVE REPAIR, AND A COX MAZE IV PROCEDURE. DURING THIS PROCEDURE, A THROMBUS MEASURING 2.5CM BY 2.5CM WAS DISCOVERED ON THE SURFACE OF THE CLOSURE DEVICE IN THE CEPHALAD POSITION. A THROMBECTOMY WAS PERFORMED. THE CENTRAL SCREW HUB OF THE CLOSURE DEVICE WAS OBSERVED TO NOT HAVE ENDOTHELIALIZED. NO PATIENT COMPLICATIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2464289 WATCHMAN LAA FLX CLOSURE DEVICE & DELIVERY SYSTEM SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL NGV BOSTON SCIENTIFIC CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 75 YR Female Required Intervention